Mark Warne

Mark has been with IP Group since 2008 identifying and commercialising intellectual property in the life science arena from UK universities. He also manages IP Group’s partnerships with the Universities of Oxford, Bristol and Bath. In addition, Mark undertakes both executive and non-executive functions for a number of IP Group life science portfolio companies. Mark joined IP Group from pre-clinical drug discovery CRO, Exelgen, where he was managing director. Mark spent eight years at Exelgen (formerly Tripos Discovery Research) where he also held positions in licensing and strategic affairs, project management and research. He has a PhD in Computational Chemistry, an MSc in Colloid Science and a BSc in Chemistry, all from the University of Bristol. Mark is a Chartered Chemist and member of the Royal Society of Chemistry.